Latest filing published 10 May 2023 for Sensus Healthcare, Inc., €6,534.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Samuel O'Rear: trading record in brief
Samuel O'Rear is a declared insider of Sensus Healthcare, Inc. (board member), with filings sourced from SEC (Form 4). We count 7 filings; the first trade dates from 8 July 2016 and the latest from 9 May 2023.
The open-market side counts 2 purchases for €55k alongside 2 sales for €691k. Sales outweigh purchases by €636k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants. So far in 2023, the count stands at 2 purchases and no sales.
Most recently, on 10 May 2023, the filings show an open-market purchase worth €48k in Sensus Healthcare, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Samuel O'Rear
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,436 shares@ US$2.94944.5% of flowCommon StockSEC:0001415889-23-007710:0Canonical exit: 6 Aug 2023 (T+90)
- 10,022 shares@ US$13.963595.5% of flowCommon StockSEC:0001415889-22-008461:0
- 10,000 shares0common stockSEC:0001415889-21-003694:0
3 of 3 declarations